je.st
news
Immuno-Oncology Promises Continued Wealth and Health: LifeTech Capital's Stephen Dunn
2015-02-20 23:54:20| Logistics - Topix.net
February 20, 2015 Immuno-oncology -- disabling cancer's defenses so that a patient's own immune system can seek it out and destroy it--took center stage in the drug development world in 2014. Stephen Dunn of LifeTech Capital believes that preeminence will continue in 2015, bolstered by new drug approvals, new targets and new combination immunotherapies that increase potency.
Tags: health
continued
stephen
wealth
Category:Transportation and Logistics